Samsung's entry via acquisition, rather than greenfield construction, is the fastest possible on-ramp into this competition
Firm Novo Nordisks global patent is set to expire in parts of the world from early 2026, allowing cut-price generic versions of Wegovy and Ozempic to be sold by other companies, according to reports
Semaglutide is a safe and effective, FDA-approved medication for both diabetes and weight loss
The GLP-1 market size 2026 is not driven by acute prescription volumes alone but by the convergence of chronic disease management and complex manufacturing
California base plans exclude GLP-1s for weight loss if your BMI is below 40 (since January 2025)
Benefit: Better Blood Sugar and Cholesterol As women navigate the menopausal transition, their ovaries produce less 17-beta-estradiol, the bodys primary form of estrogen, says Chervenak